Activities of Linezolid against Rapidly Growing Mycobacteria

AUTOR(ES)

Wallace, R. J.

FONTE

American Society for Microbiology

RESUMO

Linezolid is an oxazolidinone available as an oral drug which has activity against most gram-positive bacteria. However, few species of the genus Mycobacterium have been studied. We tested 249 clinical isolates and 10 reference strains of rapidly growing mycobacteria for susceptibility to linezolid by broth microdilution. Clinical species included the Mycobacterium fortuitum group (n = 74), M. abscessus (n = 98), M. chelonae (n = 50), M. mucogenicum (n = 10), and M. fortuitum third biovariant complex (10). The modal MIC for M. mucogenicum was 1.0 μg/ml, and the MIC at which 90% of the isolates tested are inhibited (MIC90) was 4 μg/ml; the modal MIC for the M. fortuitum group was 4 μg/ml, and the MIC90 was 16 μg/ml; the modal MIC for the M. fortuitum third biovariant complex was 4 μg/ml, and the MIC90 was 8 μg/ml; the modal MIC for M. chelonae was 8 μg/ml, and the MIC90 was 16 μg/ml; and the modal MIC for M. abscessus was 32 μg/ml, and the MIC90 was 64 μg/ml. Based on peak levels of linezolid in serum of 15 to 20 μg/ml, we propose the following broth MIC breakpoints for these species: susceptible, ≤ 8 μg/ml; moderately susceptible, 16 μg/ml; and resistant, ≥32 μg/ml). These studies demonstrate the excellent potential of linezolid for therapy of rapidly growing mycobacteria.

Documentos Relacionados

• In Vitro Activity of Linezolid against Slowly Growing Nontuberculous Mycobacteria
• Comparison of In Vitro Activities of Gatifloxacin and Ciprofloxacin against Four Taxa of Rapidly Growing Mycobacteria
• In vitro activity of clofazimine against rapidly growing nonchromogenic mycobacteria.
• Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy.
• TAXONOMIC ANALYSIS OF NONPIGMENTED, RAPIDLY GROWING MYCOBACTERIA